Knockout rats via embryo microinjection of zinc-finger nucleases AM Geurts, GJ Cost, Y Freyvert, B Zeitler, JC Miller, VM Choi, SS Jenkins, ... Science 325 (5939), 433-433, 2009 | 1237 | 2009 |
Knockout rats generated by embryo microinjection of TALENs L Tesson, C Usal, S Ménoret, E Leung, BJ Niles, S Remy, Y Santiago, ... Nature biotechnology 29 (8), 695-696, 2011 | 839 | 2011 |
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells D Duluc, Y Delneste, F Tan, MP Moles, L Grimaud, J Lenoir, L Preisser, ... Blood, The Journal of the American Society of Hematology 110 (13), 4319-4330, 2007 | 633 | 2007 |
Endothelial-to-mesenchymal transition in pulmonary hypertension B Ranchoux, F Antigny, C Rucker-Martin, A Hautefort, C Péchoux, ... Circulation 131 (11), 1006-1018, 2015 | 579 | 2015 |
Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer … I Anegón, MC Cuturi, G Trinchieri, B Perussia The Journal of experimental medicine 167 (2), 452-472, 1988 | 546 | 1988 |
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells D Chabannes, M Hill, E Merieau, J Rossignol, R Brion, JP Soulillou, ... Blood, The Journal of the American Society of Hematology 110 (10), 3691-3694, 2007 | 476 | 2007 |
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression C Chauveau, S Rémy, PJ Royer, M Hill, S Tanguy-Royer, FX Hubert, ... Blood 106 (5), 1694-1702, 2005 | 429 | 2005 |
Efficient generation of myostatin knock-out sheep using CRISPR/Cas9 technology and microinjection into zygotes M Crispo, AP Mulet, L Tesson, N Barrera, F Cuadro, PC dos Santos-Neto, ... PloS one 10 (8), e0136690, 2015 | 381 | 2015 |
Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases JB Renaud, C Boix, M Charpentier, A De Cian, J Cochennec, ... Cell reports 14 (9), 2263-2272, 2016 | 340 | 2016 |
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony … B Perussia, M Kobayashi, ME Rossi, I Anegon, G Trinchieri Journal of immunology (Baltimore, Md.: 1950) 138 (3), 765-774, 1987 | 309 | 1987 |
Fc gamma R (CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R (CD16)-induced … MA Cassatella, I Anegón, MC Cuturi, P Griskey, G Trinchieri, B Perussia The Journal of experimental medicine 169 (2), 549-567, 1989 | 298 | 1989 |
Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. B Perussia, C Ramoni, I Anegon, MC Cuturi, J Faust, G Trinchieri Natural immunity and cell growth regulation 6 (4), 171-188, 1987 | 267 | 1987 |
Production of hematopoietic colony-stimulating factors by human natural killer cells. MC Cuturi, I Anegon, F Sherman, R Loudon, SC Clark, B Perussia, ... The Journal of experimental medicine 169 (2), 569-583, 1989 | 265 | 1989 |
CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase C Guillonneau, M Hill, FX Hubert, E Chiffoleau, C Hervé, XL Li, M Heslan, ... The Journal of clinical investigation 117 (4), 1096-1106, 2007 | 240 | 2007 |
CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair M Charpentier, AHY Khedher, S Menoret, A Brion, K Lamribet, E Dardillac, ... Nature communications 9 (1), 1133, 2018 | 239 | 2018 |
Effector mechanisms of rejection A Moreau, E Varey, I Anegon, MC Cuturi Cold Spring Harbor perspectives in medicine 3 (11), a015461, 2013 | 224 | 2013 |
A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. R Josien, P Douillard, C Guillot, M Müschen, I Anegon, J Chetritt, ... The Journal of clinical investigation 102 (11), 1920-1926, 1998 | 219 | 1998 |
Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy T Larcher, A Lafoux, L Tesson, S Remy, V Thepenier, V François, ... PloS one 9 (10), e110371, 2014 | 197 | 2014 |
Heme oxygenase‐1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3‐dioxygenase M Hill, V Pereira, C Chauveau, R Zagani, S Remy, L Tesson, D Mazal, ... The FASEB Journal 19 (14), 1957-1968, 2005 | 195 | 2005 |
Transgenesis in rats: technical aspects and models B Charreau, L Tesson, JP Soulillou, C Pourcel, I Anegon Transgenic research 5, 223-234, 1996 | 195 | 1996 |